Legal & General Group
NUVB icon

Legal & General Group’s Nuvation Bio NUVB Stock Holding History

Legal & General Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
192,435
+18,263
+10% +$89.3K ﹤0.01% 2170
2026
Q1 		$747K Sell
174,172
-18,695
-10% -$104K ﹤0.01% 2237
2025
Q4 		$1.73M Sell
192,867
-29,759
-13% -$184K ﹤0.01% 2031
2025
Q3 		$823K Sell
222,626
-11,962
-5% -$32.6K ﹤0.01% 2293
2025
Q2 		$457K Buy
234,588
+10,956
+5% +$22.8K ﹤0.01% 2469
2025
Q1 		$394K Sell
223,632
-1,195
-0.5% -$2.72K ﹤0.01% 2472
2024
Q4 		$598K Buy
224,827
+78,184
+53% +$201K ﹤0.01% 2392
2024
Q3 		$336K Buy
146,643
+17,057
+13% +$52K ﹤0.01% 2581
2024
Q2 		$380K Buy
129,586
+118,181
+1,036% +$361K ﹤0.01% 2513
2024
Q1 		$41.6K Sell
11,405
-5,184
-31% -$9.96K ﹤0.01% 2804
2023
Q4 		$25.1K Sell
16,589
-72,681
-81% -$93.5K ﹤0.01% 2945
2023
Q3 		$120K Sell
89,270
-2,294
-3% -$3.82K ﹤0.01% 2809
2023
Q2 		$165K Buy
91,564
+45,975
+101% +$78.2K ﹤0.01% 2776
2023
Q1 		$75.7K Buy
45,589
+4,635
+11% +$9.39K ﹤0.01% 2817
2022
Q4 		$78.6K Hold
40,954
– – ﹤0.01% 2867
2022
Q3 		$92K Buy
40,954
+1,786
+5% +$5.1K ﹤0.01% 2846
2022
Q2 		$127K Sell
39,168
-4,474
-10% -$19.5K ﹤0.01% 2789
2022
Q1 		$230K Sell
43,642
-43
-0.1% -$242 ﹤0.01% 2622
2021
Q4 		$371K Buy
43,685
+7,067
+19% +$65K ﹤0.01% 2509
2021
Q3 		$365K Buy
36,618
+26,655
+268% +$242K ﹤0.01% 2508
2021
Q2 		$92K Buy
+9,963
New +$114K ﹤0.01% 2769

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Legal & General Group's NUVB Position: Q2 2026 in Review

Legal & General Group increased its Nuvation Bio (NUVB) stake by 10% in Q2 2026, buying an estimated $89.3K and bringing the position to 192,435 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2170.

Legal & General Group first reported a position in NUVB in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.73M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Legal & General Group held 192,435 shares of Nuvation Bio worth $1.09M as of Q2 2026.
  • Legal & General Group bought 18,263 Nuvation Bio shares in Q2 2026, an estimated $89.3K.
  • Nuvation Bio made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2170 holding.
  • Legal & General Group first reported a position in Nuvation Bio in Q2 2021 and has held it in 21 quarters since.
  • Legal & General Group's Nuvation Bio position peaked at $1.73M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.